Harpoon Therapeutics, Inc. HARP NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

46/100

2/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Harpoon Therapeutics, Inc. (HARP), dont 36 achats et 12 ventes. Le total des achats d'initiés s'élève à $494.5M et le total des ventes d'initiés à $2.38M.

Les initiés notables ayant une activité récente comprennent Merck & Co., Inc., Bailes Joseph S, Silvernail Lauren P. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — HARP

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2024-03-11	Merck & Co., Inc.	10 Percent Owner	Achat Informatif	21,397,205	$23.00	$492.14M	1,000
2024-03-11	Bailes Joseph S	Director	Restitution d'Actions	2,300	$6.66	$15.31K	-
2024-03-11	Silvernail Lauren P	Director	Restitution d'Actions	2,300	$6.66	$15.31K	-
2024-03-11	Hunt Ronald	10 Percent Owner	Restitution d'Actions	2,300	$6.66	$15.31K	-
2024-03-11	Myers Scott Dunseth	Director	Restitution d'Actions	4,600	$6.66	$30.62K	-
2024-03-11	Eastland Julia Marie	President and CEO	Restitution d'Actions	40,759	$8.90	$362.76K	-
2024-03-11	Drachman Jonathan G	Director	Restitution d'Actions	2,300	$6.66	$15.31K	-
2024-03-11	Robbins Andrew R	Director	Restitution d'Actions	2,300	$6.66	$15.31K	-
2024-03-11	Lanza Frank J	Principal Fin. & Acctng Ofc.	Restitution d'Actions	8,643	$6.97	$60.24K	-
2024-03-11	Bucher James B	Chief Legal Officer	Restitution d'Actions	110,000	$11.30	$1.24M	-
2024-03-11	Walker Luke Nathaniel	Chief Medical Officer	Restitution d'Actions	10,000	$8.90	$89K	-
2024-03-11	Chin Mark	Director	Restitution d'Actions	2,300	$6.66	$15.31K	-
2024-03-11	New Leaf Biopharma Opportunities Ii, L.p.	10 Percent Owner	Restitution d'Actions	85,750	$5.83	$500.31K	-
2024-03-08	Hunt Ronald	10 Percent Owner	Attribution de RSU	424	-	-	13,224
2024-03-08	Drachman Jonathan G	Director	Attribution de RSU	415	-	-	5,415
2024-03-08	Chin Mark	Director	Attribution de RSU	424	-	-	13,224
2024-01-07	Eastland Julia Marie	President and CEO	Attribution de RSU	178,500	-	-	232,003
2024-01-07	Lanza Frank J	Principal Fin. & Acctng Ofc.	Attribution de RSU	15,000	-	-	18,362
2024-01-07	Walker Luke Nathaniel	Chief Medical Officer	Attribution de RSU	115,000	-	-	135,000
2024-01-07	Merck & Co., Inc.	10 Percent Owner	Inconnu	-	-	-	-
2024-01-01	Hunt Ronald	10 Percent Owner	Attribution de RSU	1,072	-	-	12,801
2024-01-01	Myers Scott Dunseth	Director	Attribution de RSU	2,048	-	-	22,666
2024-01-01	Chin Mark	Director	Attribution de RSU	1,072	-	-	12,801
2023-12-21	Bucher James B	Officer	Inconnu	-	-	-	-
2023-12-21	Bucher James B	Chief Legal Officer	Attribution de RSU	110,000	$11.30	$1.24M	110,000
2023-11-27	Bailes Joseph S	Director	Attribution de RSU	5,000	-	-	5,000
2023-11-27	Silvernail Lauren P	Director	Attribution de RSU	5,000	-	-	5,000
2023-11-27	Hunt Ronald	10 Percent Owner	Attribution de RSU	5,000	-	-	11,729
2023-11-27	Myers Scott Dunseth	Director	Attribution de RSU	5,000	-	-	20,618
2023-11-27	Drachman Jonathan G	Director	Attribution de RSU	5,000	-	-	5,000
2023-11-27	Robbins Andrew R	Director	Attribution de RSU	5,000	-	-	5,000
2023-11-27	Chin Mark	Director	Attribution de RSU	5,000	-	-	11,729
2023-11-26	Eastland Julia Marie	President and CEO	Attribution de RSU	50,000	-	-	53,503
2023-11-26	Lanza Frank J	Principal Fin. & Acctng Ofc.	Attribution de RSU	2,000	-	-	3,362
2023-11-26	Walker Luke Nathaniel	Chief Medical Officer	Attribution de RSU	20,000	-	-	20,000
2023-10-25	Hunt Ronald	10 Percent Owner	Achat Informatif	85,750	$5.83	$500.31K	85,750
2023-10-25	New Leaf Biopharma Opportunities Ii, L.p.	10 Percent Owner	Achat Informatif	85,750	$5.83	$500.31K	85,750
2023-10-01	Hunt Ronald	10 Percent Owner	Attribution de RSU	3,035	-	-	6,729
2023-10-01	Myers Scott Dunseth	Director	Attribution de RSU	5,797	-	-	15,618
2023-10-01	Chin Mark	Director	Attribution de RSU	3,035	-	-	6,729
2023-07-01	Hunt Ronald	10 Percent Owner	Attribution de RSU	18,656	-	-	36,941
2023-07-01	Myers Scott Dunseth	Director	Attribution de RSU	35,634	-	-	98,215
2023-07-01	Chin Mark	Director	Attribution de RSU	18,656	-	-	36,941
2023-06-22	Bailes Joseph S	Director	Attribution de RSU	23,000	$0.67	$15.31K	23,000
2023-06-22	Silvernail Lauren P	Director	Attribution de RSU	23,000	$0.67	$15.31K	23,000
2023-06-22	Hunt Ronald	10 Percent Owner	Attribution de RSU	23,000	$0.67	$15.31K	23,000
2023-06-22	Myers Scott Dunseth	Director	Attribution de RSU	46,000	$0.67	$30.62K	46,000
2023-06-22	Drachman Jonathan G	Director	Attribution de RSU	23,000	$0.67	$15.31K	23,000
2023-06-22	Robbins Andrew R	Director	Attribution de RSU	23,000	$0.67	$15.31K	23,000
2023-06-22	Chin Mark	Director	Attribution de RSU	23,000	$0.67	$15.31K	23,000

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration